Skip to main content

Market Overview

50 Stocks Moving In Tuesday's Mid-Day Session

Share:

Gainers

  • UQM Technologies, Inc. (NYSW: UQM) shares jumped 46 percent to $1.6441 after the company agreed to be acquired by Danfoss for $1.71 per share in cash.
  • Staffing 360 Solutions Inc (NASDAQ: STAF) shares climbed 32.3 percent to $2.70 after the company re-signed its largest client to a multi-year contract.
  • Mediwound Ltd (NASDAQ: MDWD) shares gained 31.8 percent to $5.77 after the company disclosed that its Phase 3 study of NexoBrid met primary and all secondary endpoints with statistically significant results compared with control group.
  • Neovasc Inc (NASDAQ: NVCN) gained 21 percent to $0.91 after the company announced dismissal of a patent infringement claim by Edwards Lifesciences.
  • Daseke, Inc. (NASDAQ: DSKE) shares rose 12.3 percent to $4.75.
  • Titan Medical Inc. (NASDAQ: TMDI) rose 12.1 percent to $3.70.
  • TRACON Pharmaceuticals Inc (NASDAQ: TCON) gained 11.5 percent to $1.07 after reporting positive data from ongoing Phase 1b/2 trial of TRC105 in hepatocellular carcinoma.
  • ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 9.7 percent to $3.23.
  • Leap Therapeutics, Inc. (NASDAQ: LPTX) shares gained 9.6 percent to $3.2500.
  • Bionano Genomics, Inc. (NASDAQ: BNGO) surged 9.4 percent to $4.8996.
  • PG&E Corporation (NYSE: PCG) shares gained 9.3 percent to $7.91. PG&E announced $5.5 billion of debtor-in-possession financing.
  • Centrus Energy Corp. (NYSE: LEU) climbed 9.3 percent to $2.3486.
  • Aphria Inc. (NYSE: APHA) rose 8.1 percent to $7.21 after gaining 3.09 percent on Friday.
  • Nymox Pharmaceutical Corporation (NASDAQ: NYMX) gained 8.1 percent to $2.4415.
  • eBay Inc (NASDAQ: EBAY) climbed 7.7 percent to $33.40 after hedge fund Elliot Management announced a large stake in the company and said the stock could be worth $55 to $63 per share.
  • Barnes & Noble Education, Inc. (NYSE: BNED) gained 7.1 percent to $5.63.
  • Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) surged 6.8 percent to $2.50.
  • Ryanair Holdings plc (NASDAQ: RYAAY) gained 6.3 percent to $69.89. Ryanair lowered its fiscal 2019 profit after tax guidance from EUR1.1 billion-EUR1.2 billion, to EUR1.0 billion - EUR1.1 billion. HBSC upgraded the company's shares from Hold to Buy.
  • New Oriental Education & Technology Group Inc. (NYSE: EDU) rose 5.8 percent to $69.72 after reporting upbeat Q2 results.
  • KBS Fashion Group Ltd (NASDAQ: KBSF) gained 5.3 percent to $3.82 after the company announced that it expects to be profitable in FY19.
  • MOGU Inc. (NYSE: MOGU) climbed 5.2 percent to $16.78. Morgan Stanley initiated coverage on Mogu with a Equal-Weight rating.

Check out these big penny stock gainers and losers

Losers

  • Arconic Inc (NYSE: ARNC) shares tumbled 17.4 percent to $16.81 after the company announced its Board of Directors has determined to no longer pursue a potential sale of the company.
  • Editas Medicine, Inc. (NASDAQ: EDIT) shares declined 21 percent to $20.65 after the President and CEO of the company announced she will be stepping down from her position.
  • Oasmia Pharmaceutical AB (NASDAQ: OASM) fell 19.4 percent to $2.6192 after the company cancelled its extraordinary general meeting.
  • Organogenesis Holdings Inc. (NASDAQ: ORGO) shares dropped 17 percent to $25.20.
  • Phunware Inc. (NASDAQ: PHUN) shares dropped 16.1 percent to $125.00.
  • Microbot Medical Inc. (NASDAQ: MBOT) shares declined 15.1 percent to $7.30.
  • Biocept, Inc. (NASDAQ: BIOC) shares fell 14.9 percent to $1.9499 after dropping 24.42 percent on Friday.
  • Stanley Black & Decker, Inc. (NYSE: SWK) dipped 14.3 percent to $117.32 after the company issued weak FY19 EPS guidance, offsetting strong Q4 earnings.
  • ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) fell 14.3 percent to $3.06.
  • Star Bulk Carriers Corp. (NASDAQ: SBLK) shares dropped 13.8 percent to $9.00.
  • B Communications Ltd (NASDAQ: BCOM) shares fell 13.6 percent to $4.75.
  • AGM Group Holdings Inc. (NASDAQ: AGMH) dropped 12.8 percent to $28.00.
  • Liquid Media Group Ltd. (NASDAQ: YVR) shares declined 12 percent to $2.12.
  • CRISPR Therapeutics AG (NASDAQ: CRSP) slipped 12 percent to $32.69. CRISPR Therapeutics and ProBioGen reported collaboration and license agreement to develop novel in vivo delivery technologies. Citigroup downgraded CRISPR Therapeutics from Neutral to Sell.
  • Weibo Corporation (NASDAQ: WB) fell 11.8 percent to $53.64 after Nomura downgraded the company's stock from Buy to Neutral and lowered its price target from $74 per share to $61 per share.
  • Cocrystal Pharma, Inc. (NASDAQ: COCP) shares dropped 11.1 percent to $3.4326 after the company issued an update on clinical development program evaluating CC-31244 for ultra-short treatment of hepatitis C virus.
  • Crescent Point Energy Corp. (NYSE: CPG) shares declined 10.9 percent to $3.1201.
  • Duluth Holdings Inc. (NASDAQ: DLTH) fell 10.3 percent to $21.23.
  • Attunity Ltd. (NASDAQ: ATTU) dipped 10.2 percent to $22.17.
  • Telecom Italia S.p.A. (NYSE: TI) fell 9.4 percent to $5.02 after declining 5.46 percent on Friday.
  • Huazhu Group Limited (NASDAQ: HTHT) dipped 8.9 percent to $31.84 after Deutsche Bank downgraded the company's stock from Hold to Sell.
  • PetMed Express, Inc. (NASDAQ: PETS) fell 8.6 percent to $21.43 after reporting Q3 earnings.

  • Golden Ocean Group Limited (NASDAQ: GOGL) fell 8 percent to $6.18 after rising 3.71 percent on Friday.
  • Pan American Silver Corp. (NASDAQ: PAAS) tumbled 7.5 percent to $13.12 after the company's silver production fell short of guidance.
  • Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares dropped 7.2 percent to $14.10.
  • Altria Group Inc (NYSE: MO) dipped 6.1 percent to $45.37. Morgan Stanley downgraded Altria from Equal-Weight to Underweight.
  • Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) fell 5.8 percent to $7.11 following the release of clinical trial results. Aurinia said a mid-stage study that evaluated its dry eye syndrome treatment Voclosporin ophthalmic solution (VOS) --0.2 percent-- demonstrated statistically superior efficacy versus Allergan's Restasis -- 0.05 percent. The company said there was no statistical difference between VOS and Restasis in the primary endpoint of discomfort, both showing low scores. VOS was slightly less tolerable than Restasis.
  • Halliburton Company (NYSE: HAL) dropped 5.5 percent to $30.49 following Q4 results.
  • UBS Group AG (NYSE: UBS) fell 4.9 percent to $12.94 after reporting weak Q4 earnings.
 

Related Articles (AGMH + APHA)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com